{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:25:26Z","timestamp":1767857126613,"version":"3.49.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00498","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T05:16:46Z","timestamp":1552972606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against B. anthracis Spores and Toxin"],"prefix":"10.3389","volume":"10","author":[{"given":"Saugata","family":"Majumder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas Kumar","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivakiran S.","family":"Makam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"B1","volume-title":"Anthrax in Humans and Animals","author":"Turnbull","year":"2008"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/brv.12420","article-title":"Spores and soil from six sides: interdisciplinarity and the environmental biology of anthrax (Bacillus anthracis)","volume":"93","author":"Carlson","year":"2018","journal-title":"Biol Rev Camb Philos Soc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0966-842X(02)02422-8","article-title":"The alveolar macrophage: the Trojan horse of Bacillus anthracis","volume":"10","author":"Guidi-Rontani","year":"2002","journal-title":"Trends Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1086\/382656","article-title":"Time-lapse confocal imaging of development of Bacillus anthracis in macrophages","volume":"189","author":"Ruthel","year":"2004","journal-title":"J Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1084\/jem.20041557","article-title":"Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling","volume":"201","author":"Paccani","year":"2005","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"8275","DOI":"10.1128\/IAI.73.12.8275-8281.2005","article-title":"Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo","volume":"73","author":"Comer","year":"2005","journal-title":"Infect Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.mam.2009.06.002","article-title":"Anthrax toxins: a weapon to systematically dismantle the host immune defenses","volume":"30","author":"Tournier","year":"2009","journal-title":"Mol Aspects Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0002-9440(10)61218-7","article-title":"Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice","volume":"167","author":"Firoved","year":"2005","journal-title":"Am J Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/SHK.0b013e318067da56","article-title":"A mathematical simulation of the inflammatory response to anthrax infection","volume":"29","author":"Kumar","year":"2008","journal-title":"Shock"},{"key":"B10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature."},{"key":"B11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/187220811797579097","article-title":"Recent progress in the development of anthrax vaccines","volume":"5","author":"Kaur","year":"2011","journal-title":"Recent Pat Biotechnol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-9433-4-4","article-title":"Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin","volume":"4","author":"Wang","year":"2005","journal-title":"Med Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1099\/jmm.0.045393-0","article-title":"Characterization of a multi-component anthrax vaccine designed to target in the initial stages of infection as well as toxemia","volume":"61","author":"Cote","year":"2012","journal-title":"J Med Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect Immun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1128\/IAI.01217-08","article-title":"Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax","volume":"77","author":"Gauthier","year":"2009","journal-title":"Infect Immun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1128\/JB.187.17.5868-5876.2005","article-title":"Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis","volume":"187","author":"Steichen","year":"2005","journal-title":"J Bacteriol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1016\/j.vaccine.2008.07.015","article-title":"Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen","volume":"26","author":"Cybulski","year":"2008","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tibtech.2008.08.002","article-title":"Structure-based antigen design: a strategy for next generation vaccines","volume":"26","author":"Dormitzer","year":"2008","journal-title":"Trends Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1172\/JCI38330","article-title":"Vaccinology in the genome era","volume":"119","author":"Rinaudo","year":"2009","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1073\/pnas.1106590108","article-title":"Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections","volume":"108","author":"Nuccitelli","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061885","article-title":"A single-dose PLGA encapsulated protective antigen domain 4 nano formulation protects mice against Bacillus anthracis spore challenge","author":"Manish","year":"2013","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1038\/s41598-018-25502-9","article-title":"A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis","volume":"8","author":"Majumder","year":"2018","journal-title":"Sci Rep."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","author":"Olsen","year":"2010","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2014.01.012","article-title":"Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model","volume":"59","author":"Makam","year":"2014","journal-title":"Mol. Immunol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/AEM.64.3.982-991.1998","article-title":"Fermentation, purification, and characterization of protective antigen from a recombinant, a virulent strain of Bacillus anthracis","volume":"64","author":"Farchaus","year":"1998","journal-title":"App Environ Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijfoodmicro.2007.02.012","article-title":"Germination of Bacillus cereus spores adhered to stainless steel","volume":"116","author":"Hornstra","year":"2007","journal-title":"Int J Food Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-662-05767-4","article-title":"Anthrax vaccines","volume":"271","author":"Friedlander","year":"2002","journal-title":"Curr Top Microbiol Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1128\/IAI.00660-07","article-title":"Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity","volume":"75","author":"Brahmbhatt","year":"2007","journal-title":"Infect Immun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1016\/j.vaccine.2010.07.075","article-title":"An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor","volume":"28","author":"Baillie","year":"2010","journal-title":"Vaccine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.molimm.2008.12.031","article-title":"Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis","volume":"46","author":"Kaur","year":"2009","journal-title":"Mol Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.vaccine.2014.01.044","article-title":"A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice","volume":"32","author":"Singh","year":"2014","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1128\/IAI.73.11.7495-7501.2005","article-title":"Murine macrophages kill the vegetative form of Bacillus anthracis","volume":"73","author":"Kang","year":"2005","journal-title":"Infect Immun."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000329","article-title":"Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation","author":"Scobie","year":"2007","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8266","DOI":"10.1128\/IAI.73.12.8266-8274.2005","article-title":"Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge","volume":"73","author":"Koya","year":"2005","journal-title":"Infect Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1128\/AAC.00546-16","article-title":"Revisiting the concept of targeting only Bacillus anthracis toxins asa treatment for anthrax","volume":"60","author":"Glinert","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molimm.2011.11.007","article-title":"S-layer homology motif is an immunogen and confers protection to mouse model against anthrax","volume":"50","author":"Kulshreshtha","year":"2012","journal-title":"Mol Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0923-2494(97)85217-0","article-title":"CD8+ T Cells in bacterial infections of mice","volume":"147","author":"White","year":"1996","journal-title":"Res Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00498\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T22:27:57Z","timestamp":1606861677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00498\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2019.00498"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00498","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"article-number":"498"}}